C-reactive protein levels before reduced-intensity conditioning predict outcome after allogeneic stem cell transplantation

被引:15
作者
Remberger, Mats [1 ,2 ]
Mattsson, Jonas [2 ]
机构
[1] Karolinska Univ Hosp, Div Clin Immunol, S-14186 Stockholm, Sweden
[2] Karolinska Univ Hosp, Ctr Allogene Stem Cell Transplantat, Karolinska Inst, S-14186 Stockholm, Sweden
关键词
CRP; RIC; HSCT; TRM; MARROW-TRANSPLANTATION; HOST-DISEASE; ACUTE GRAFT; COMPLICATIONS; MORTALITY; INFECTION; CHILDREN; LEUKEMIA; PROGRESS;
D O I
10.1007/s12185-010-0632-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The prognostic value of CRP levels before conditioning for allogeneic stem-cell transplantation (ASCT) was evaluated. Reduced-intensity conditioning (RIC) was given to 205 patients and conventional myeloablative conditioning (MAC) to 299 patients. Most patients had an HLA-compatible related or unrelated donor. There were 287 males and 216 females, median age 36 (1-69) years. Most patients received peripheral blood stem cells. Increased CRP levels (> 10 mg/L) were detected in 129 patients (26%). Overall survival (OS) and transplant-related mortality (TRM) were worse for RIC patients with elevated CRP (67 vs. 43%, p = 0.005, and 16 vs. 30%, p = 0.036) while no difference was seen in MAC patients. An infection at the start of conditioning was seen in 27 RIC patients. We identified a subgroup of patients with an infection and elevated CRP (n = 16) and these patients had the worst outcome. In multivariate analysis, both infection and elevated CRP was the strongest factor associated with OS (HR 3.27, p < 0.001) and TRM (HR 4.35, p < 0.001). No correlation between any outcome variable and CRP was seen in MAC-treated patients. CRP may be a good prognostic factor for outcome after RIC and ASCT. It should be analyzed before conditioning, especially in patients with coexisting infection since patients with increased CRP and infection seem to have a very poor outcome after ASCT.
引用
收藏
页码:161 / 167
页数:7
相关论文
共 26 条
[1]  
[Anonymous], 2011, The statistical analysis of failure time data
[2]   Pretreatment C-Reactive Protein Is a Predictor for Outcomes after Reduced-intensity Allogeneic Hematopoietic Cell Transplantation [J].
Artz, Andrew S. ;
Wickrema, Amittha ;
Dinner, Shira ;
Godley, Lucy A. ;
Kocherginsky, Masha ;
Odenike, Olatoyosi ;
Rich, Elizabeth S. ;
Stock, Wendy ;
Ulaszek, Jodie ;
Larson, Richard A. ;
van Besien, Koen .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (11) :1209-1216
[3]   Allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning as treatment for hematologic malignancies and inherited blood disorders [J].
Baron, F ;
Storb, R .
MOLECULAR THERAPY, 2006, 13 (01) :26-41
[4]   Unrelated donor status and high donor age independently affect immunologic recovery after nonmyeloablative conditioning [J].
Baron, Frederic ;
Storer, Barry ;
Maris, Michael B. ;
Storek, Jan ;
Piette, Fanny ;
Metcalf, Monja ;
White, Kristen ;
Sandmaier, Brenda M. ;
Maloney, David G. ;
Storb, Rainer ;
Boeckh, Michael .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (11) :1176-1187
[5]   Medical progress: Hematopoietic stem-cell transplantation [J].
Copelan, EA .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (17) :1813-1826
[6]   An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer [J].
Crumley, A. B. C. ;
McMillan, D. C. ;
McKernan, M. ;
Going, J. J. ;
Shearer, C. J. ;
Stuart, R. C. .
BRITISH JOURNAL OF CANCER, 2006, 94 (11) :1568-1571
[7]   Polymorphisms of cytokine and innate immunity genes and GVHD [J].
Dickinson, A. M. ;
Holler, E. .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2008, 21 (02) :149-164
[8]  
FORSLOW U, 2009, BONE MARROW TRANSPLA
[9]   Decreasing mortality rate in early pneumonia following hematopoietic stem cell transplantation [J].
Forslow, Ulrica ;
Mattsson, Jonas ;
Ringden, Olle ;
Klominek, Julius ;
Remberger, Mats .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2006, 38 (11-12) :970-976
[10]   Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation [J].
Fuji, Shigeo ;
Kim, Sung-Won ;
Fukuda, Takahiro ;
Mori, Shin-Ichiro ;
Yamasaki, Satoshi ;
Morita-Hoshi, Yuriko ;
Ohara-Waki, Fusako ;
Heike, Yuji ;
Tobinai, Kensei ;
Tanosaki, Ryuji ;
Takaue, Yoichi .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (05) :510-517